These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23323889)

  • 1. Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs.
    Bittencourt MK; de Vasconcellos JP; Bittencourt MD; Malagó R; Bacellar M
    J Ocul Pharmacol Ther; 2013 May; 29(4):431-6. PubMed ID: 23323889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
    Yücel OE; Artürk N
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
    Nestor MS; Han H; Gade A; Fischer D; Saban Y; Polselli R
    J Cosmet Dermatol; 2021 Oct; 20(10):3133-3146. PubMed ID: 34378298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
    Sadiq SA; Dharmasena A
    Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
    Ellis MF; Daniell M
    Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
    Bernardini FP; Skippen B; Croasdell B; Cerón Bohórquez JM; Murray G; Sayed K; Walker L; Hartstein ME;
    Aesthet Surg J; 2023 Aug; 43(9):955-961. PubMed ID: 36943792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
    Reddy UP; Woodward JA
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
    Girard B; Piaton JM; Keller P; Nguyen TH
    J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphometric analysis of the palpebral fissure in patients with thyroid-related disfunction before and after application of botulinum toxin].
    Costa PG; Saraiva FP; Matayoshi S
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):920-5. PubMed ID: 17160217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apraclonidine in the treatment of ptosis.
    Wijemanne S; Vijayakumar D; Jankovic J
    J Neurol Sci; 2017 May; 376():129-132. PubMed ID: 28431598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A induced protective ptosis.
    Adams GG; Kirkness CM; Lee JP
    Eye (Lond); 1987; 1 ( Pt 5)():603-8. PubMed ID: 3446541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cornea protection in ptosis induced by botulinum injection].
    Brans JW; Aramideh M; Schlingemann RO; Oen VM; Speelman JD; Ongerboer de Visser BW
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1031-3. PubMed ID: 8684496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
    Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N;
    Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm.
    Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A
    Eur J Neurol; 2009 Mar; 16(3):392-8. PubMed ID: 19364366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.